Bank of New York Mellon’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.8M Sell
94,045
-14,269
-13% -$6M 0.01% 1149
2026
Q1
$40.9M Sell
108,314
-894
-0.8% -$383K 0.01% 1120
2025
Q4
$46.7M Sell
109,208
-13,162
-11% -$5.73M 0.01% 1052
2025
Q3
$54.8M Sell
122,370
-9,552
-7% -$4.33M 0.01% 954
2025
Q2
$64.2M Sell
131,922
-14,115
-10% -$8.04M 0.01% 837
2025
Q1
$89.9M Buy
146,037
+3,782
+3% +$2.15M 0.02% 663
2024
Q4
$75.4M Buy
142,255
+4,838
+4% +$2.73M 0.01% 779
2024
Q3
$82.6M Sell
137,417
-13,969
-9% -$7.92M 0.02% 742
2024
Q2
$82.1M Buy
151,386
+1,156
+0.8% +$662K 0.02% 742
2024
Q1
$96.4M Sell
150,230
-7,999
-5% -$4.86M 0.02% 677
2023
Q4
$92.5M Buy
158,229
+88
+0.1% +$49.2K 0.02% 689
2023
Q3
$82.2M Sell
158,141
-6,125
-4% -$3.18M 0.02% 713
2023
Q2
$89M Sell
164,266
-3,305
-2% -$1.81M 0.02% 674
2023
Q1
$90.1M Sell
167,571
-274
-0.2% -$140K 0.02% 669
2022
Q4
$85.7M Buy
167,845
+2,115
+1% +$1.03M 0.02% 684
2022
Q3
$72.4M Sell
165,730
-2,303
-1% -$1.11M 0.02% 731
2022
Q2
$78.9M Buy
168,033
+215
+0.1% +$105K 0.02% 705
2022
Q1
$85M Sell
167,818
-2,165
-1% -$1.04M 0.02% 762
2021
Q4
$89.9M Sell
169,983
-2,206
-1% -$1.06M 0.02% 763
2021
Q3
$80.1M Sell
172,189
-8,554
-5% -$4.03M 0.02% 812
2021
Q2
$85.8M Buy
180,743
+2,348
+1% +$1.13M 0.02% 793
2021
Q1
$82M Sell
178,395
-11,936
-6% -$5.85M 0.02% 805
2020
Q4
$101M Buy
190,331
+1,946
+1% +$956K 0.02% 646
2020
Q3
$90.5M Sell
188,385
-12,883
-6% -$6.32M 0.02% 607
2020
Q2
$90.8M Sell
201,268
-290
-0.1% -$129K 0.02% 574
2020
Q1
$87.3M Buy
201,558
+8,425
+4% +$3.76M 0.03% 512
2019
Q4
$84.8M Sell
193,133
-5,355
-3% -$2.25M 0.02% 686
2019
Q3
$82.9M Sell
198,488
-2,987
-1% -$1.22M 0.02% 671
2019
Q2
$72.7M Buy
201,475
+8,586
+4% +$2.87M 0.02% 756
2019
Q1
$61.7M Sell
192,889
-48,918
-20% -$15M 0.02% 828
2018
Q4
$68.5M Sell
241,807
-8,608
-3% -$2.6M 0.02% 715
2018
Q3
$80M Sell
250,415
-1,981
-0.8% -$631K 0.02% 730
2018
Q2
$81.2M Sell
252,396
-15,612
-6% -$4.89M 0.02% 714
2018
Q1
$73.1M Buy
268,008
+52,460
+24% +$13.9M 0.02% 759
2017
Q4
$52.4M Sell
215,548
-18,896
-8% -$4.29M 0.01% 987
2017
Q3
$47.4M Sell
234,444
-8,209
-3% -$1.61M 0.01% 1029
2017
Q2
$49.6M Sell
242,653
-10,512
-4% -$2.09M 0.01% 975
2017
Q1
$46.3M Sell
253,165
-73,047
-22% -$12.7M 0.01% 1008
2016
Q4
$52.3M Buy
326,212
+22,392
+7% +$3.29M 0.02% 914
2016
Q3
$42.9M Sell
303,820
-5,484
-2% -$763K 0.01% 973
2016
Q2
$42.2M Sell
309,304
-20,594
-6% -$2.73M 0.01% 962
2016
Q1
$44.7M Buy
329,898
+17,518
+6% +$2.37M 0.01% 926
2015
Q4
$46.8M Sell
312,380
-17,242
-5% -$2.55M 0.01% 882
2015
Q3
$44M Buy
329,622
+35,420
+12% +$4.96M 0.01% 915
2015
Q2
$38.6M Buy
294,202
+9,843
+3% +$1.22M 0.01% 1050
2015
Q1
$34M Buy
284,359
+65,598
+30% +$7.28M 0.01% 1118
2014
Q4
$23.1M Sell
218,761
-28,031
-11% -$2.96M 0.01% 1363
2014
Q3
$25.4M Sell
246,792
-48,317
-16% -$4.9M 0.01% 1278
2014
Q2
$27.7M Sell
295,109
-23,035
-7% -$2.04M 0.01% 1247
2014
Q1
$28.5M Sell
318,144
-134,753
-30% -$11M 0.01% 1245
2013
Q4
$34.7M Sell
452,897
-10,131
-2% -$747K 0.01% 1104
2013
Q3
$33.1M Buy
463,028
+52,900
+13% +$3.76M 0.01% 1096
2013
Q2
$29.7M Buy
+410,128
New +$30.1M 0.01% 1122

Other funds holding CHE

Bank of New York Mellon's CHE Position: Q2 2026 in Review

Bank of New York Mellon reduced its Chemed (CHE) stake by 13% in Q2 2026, selling an estimated $6M and leaving 94,045 shares worth $43.8M. The position accounts for 0.01% of the portfolio, ranked #1149.

Bank of New York Mellon first reported a position in CHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $101M in Q4 2020. 298 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Bank of New York Mellon held 94,045 shares of Chemed worth $43.8M as of Q2 2026.
  • Bank of New York Mellon sold 14,269 Chemed shares in Q2 2026, an estimated $6M.
  • Chemed made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1149 holding.
  • Bank of New York Mellon first reported a position in Chemed in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Chemed position peaked at $101M in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.